Milestone Pharmaceuticals Inc. Shares Outstanding
Milestone Pharmaceuticals Inc. (MIST) had Shares Outstanding of 124.50 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-12
- 2026-06-30: Shares outstanding (split-adjusted) 124.50M shares; Shares authorized (split-adjusted) (m).
- 2026-03-31: Shares outstanding (split-adjusted) 117.79M shares; Shares authorized (split-adjusted) (m).
- 2025-12-31: Shares outstanding (split-adjusted) 106.24M shares; Shares authorized (split-adjusted) (m).
- 2025-09-30: Shares outstanding (split-adjusted) 85.17M shares; Shares authorized (split-adjusted) (m).
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 124.50M shares 10-Q · filed 2026-08-12 | (m) |
| 2026-03-31 | 117.79M shares 10-Q · filed 2026-05-13 | (m) |
| 2025-12-31 | 106.24M shares 10-Q · filed 2026-08-12 | (m) |
| 2025-09-30 | 85.17M shares 10-Q · filed 2025-11-12 | (m) |
| 2025-06-30 | 53.49M shares 10-Q · filed 2025-08-12 | (m) |
| 2025-03-31 | 53.46M shares 10-Q · filed 2025-05-14 | (m) |
| 2024-12-31 | 53.35M shares 10-K · filed 2026-03-20 | (m) |
| 2024-09-30 | 53.33M shares 10-Q · filed 2024-11-12 | (m) |
| 2024-06-30 | 53.27M shares 10-Q · filed 2024-08-08 | (m) |
| 2024-03-31 | 53.25M shares 10-Q · filed 2024-05-13 | (m) |
| 2023-12-31 | 33.48M shares 10-K · filed 2025-03-13 | (m) |
| 2023-09-30 | 33.48M shares 10-Q · filed 2023-11-13 | (m) |
| 2023-06-30 | 33.36M shares 10-Q · filed 2023-08-10 | (m) |
| 2023-03-31 | 33.34M shares 10-Q · filed 2023-05-11 | (m) |
| 2022-12-31 | 34.29M shares 10-K · filed 2024-03-21 | (m) |
| 2022-09-30 | 30.39M shares 10-Q · filed 2022-11-10 | (m) |
| 2022-06-30 | 30.01M shares 10-Q · filed 2022-08-10 | (m) |
| 2022-03-31 | 29.92M shares 10-Q · filed 2022-05-12 | (m) |
| 2021-12-31 | 29.90M shares 10-K · filed 2023-03-29 | (m) |
| 2021-09-30 | 29.87M shares 10-Q · filed 2021-11-12 | (m) |
| 2021-06-30 | 29.85M shares 10-Q · filed 2021-08-11 | (m) |
| 2021-03-31 | 29.85M shares 10-Q · filed 2021-05-17 | (m) |
| 2020-12-31 | 29.83M shares 10-K · filed 2022-03-24 | (m) |
| 2020-09-30 | 24.73M shares 10-Q · filed 2020-11-13 | (m) |
| 2020-06-30 | 24.69M shares 10-Q · filed 2020-08-12 | (m) |
| 2020-03-31 | 24.56M shares 10-Q · filed 2020-05-14 | (m) |
| 2019-12-31 | 24.51M shares 10-K · filed 2021-03-29 | (m) |
| 2019-09-30 | 24.49M shares 10-Q · filed 2019-11-13 | (m) |
| 2019-06-30 | 24.49M shares 10-Q · filed 2019-08-13 | (m) |
| 2019-03-31 | 614.94K shares 10-Q · filed 2019-06-19 | (m) |
| 2018-12-31 | 596.79K shares 10-K/A · filed 2020-10-23 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |